TY  - CONF

T1  - 437 Treatment-emergent adverse events in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis treated with dupilumab in an open-label extension clinical trial

JO  - British Journal of Dermatology

UR  - http://dx.doi.org/10.1093/bjd/ljad162.057

PY  - 2023/06/20

AU  - Paller AS

AU  - Siegfried EC

AU  - Sidbury R

AU  - Lockshin B

AU  - Cork M

AU  - Pinter A

AU  - Xiao J

AU  - Khokhar FA

AU  - Bansal A

AU  - Prescilla R

ED  - 

DO  - DOI: 10.1093/bjd/ljad162.057

PB  - Oxford University Press (OUP)

VL  - 188

IS  - Supplement_3

Y2  - 2024/12/22

ER  -